Two biotech stocks plunge after losing patent fights
March 31, 2017 at 15:57 PM EDT
According to a filing from the U.S. Patent and Trademark Office, Forward Pharma has been interfering with Biogen.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.